06 / REFERENCES & SOURCES

Every study,
a traceable source.

We introduce research developments through original papers and provide references for our company history, R&D programs and public announcements. Literature review date: October 2, 2026.

Side view of an eGreen LED-cultivated Sanghuang fruiting body, showing its rounded golden form and surface detail
LED-cultivated Sanghuang · form

TRACEABLE BY DESIGN

Follow the summary back to the source.

We retain study identifiers, links to original papers and corporate references to help you understand the background of our research, programs and milestones. Please consider the dates and research stages alongside the content.

Publications & Trial Registry

29 entries: including 1 dissertation, 1 experimental registration and 1 study on P. igniarius related taxa. R20 only checks the bibliography, R25 simultaneously checks the 2019 author institution corrections. Data verification date 2026-10-02.

Download document classification CSV

The following are external academic studies and do not represent execution by eGreen or use of eGreen raw materials.

R5

2014 · In vitro cell research

Study on Hispolon and apoptosis of nasopharyngeal carcinoma cells

Phytomedicine 21, 1746–1752

Hispolon from Phellinus linteus possesses mediate caspases activation and induces human nasopharyngeal carcinomas cells apoptosis through ERK1/2, JNK1/2 and p38 MAPK pathway.

DOI: 10.1016/j.phymed.2014.07.013

Original publication & bibliographic recordRead the study summary
R6

2021 · Species Identification Research

Clarifying the species identity of Sanghuang using ITS barcodes

IMA Fungus · PMID 33853671

Addressing widespread misidentifications of traditional medicinal mushrooms in Sanghuangporus (Basidiomycota) through ITS barcoding and designation of reference sequences.

DOI: 10.1186/s43008-021-00059-x

Original publication & bibliographic recordRead the study summary
R15

2019 · Human retrospective study

Pancreatic cancer: study on completion of postoperative adjuvant therapy

Lee et al. · Integrative Cancer Therapies 18

Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score-Matched Analysis.

DOI: 10.1177/1534735418816825

Original publication & bibliographic recordRead the study summary
R18

2004 · Single case report

Prostate cancer: Evidence positioning in early case literature

Shibata et al. · Urologia Internationalis 73(2), 188–190

Dramatic remission of hormone refractory prostate cancer achieved with extract of the mushroom, Phellinus linteus.

DOI: 10.1159/000079704

Original publication & bibliographic recordRead the study summary
R21

2021 · Taiwan·Animal Research

Sanghuang mycelium and drug-induced liver injury

Jiang et al. · Antioxidants 10(6), 897

Sanghuangporus sanghuang Mycelium Prevents Paracetamol-Induced Hepatotoxicity through Regulating the MAPK/NF-κB, Keap1/Nrf2/HO-1, TLR4/PI3K/Akt, and CaMKKβ/LKB1/AMPK Pathways and Suppressing Oxidative Stress and Inflammation.

DOI: 10.3390/antiox10060897

Original publication & bibliographic recordRead the study summary
R22

2022 · Animal Metabolism Research

Type 2 diabetic mice: polysaccharides, blood glucose and bacteria

Huang et al. · Frontiers in Nutrition 9, 1013466

Sanghuangporus vaninii fruit body polysaccharide alleviates hyperglycemia and hyperlipidemia via modulating intestinal microflora in type 2 diabetic mice.

DOI: 10.3389/fnut.2022.1013466

Original publication & bibliographic recordRead the study summary
R23

2024 · Research on microbiota and animal mechanism

Mechanism of enteritis: bacteria, 5-HIAA and AhR

Zhong et al. · iMeta 3, e180

The gut microbiota-aromatic hydrocarbon receptor (AhR) axis mediates the anticolitic effect of polyphenol-rich extracts from Sanghuangporus.

DOI: 10.1002/imt2.180

Original publication & bibliographic recordRead the study summary
R24

2023 · Taiwan’s participation in cell research

Triple-negative breast cancer: MHME and SRC/STAT3

Liao et al. · Biomedicines 11(10), 2742

Methoxyhispolon Methyl Ether, a Hispolon Analog, Thwarts the SRC/STAT3/BCL-2 Axis to Provoke Human Triple-Negative Breast Cancer Cell Apoptosis In Vitro.

DOI: 10.3390/biomedicines11102742

Original publication & bibliographic recordRead the study summary
R25

2017 · Taiwan·Cell Research

Hispidin and glycation stress in neural cells

Song et al. · Oxidative Medicine and Cellular Longevity 2017, 4824371

Protective Effects and Possible Mechanisms of Ergothioneine and Hispidin against Methylglyoxal-Induced Injuries in Rat Pheochromocytoma Cells.

DOI: 10.1155/2017/4824371

Original publication & bibliographic recordRead the study summary
R28

2017 · Cell and Animal Tumor Research

KRAS mutated colorectal cancer: cetuximab sensitivity

Park et al. · International Journal of Molecular Sciences 18(8), 1746

Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer.

DOI: 10.3390/ijms18081746

Original publication & bibliographic recordRead the study summary
R29

2026 · Related species · human randomized trial

P. igniarius: study on immunity after chemotherapy for colorectal cancer

Zhang et al. · Journal of Traditional and Complementary Medicine

A prospective clinical study on the effectiveness of Phellinus igniarius decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy.

DOI: 10.1016/j.jtcme.2026.05.002

Original publication & bibliographic recordRead the study summary

Company & public records

C1

Corporate overview · 2026

eGreen Biotek 2026 Introduction

History: Page 4; Cultivation, Quality and Laboratory: Pages 5–7; International Research Context: Page 9; Company Pilot Research: Pages 22–28; R&D Plan: Page 30; Contact Information: Page 49.

We distinguish our own R&D progress from external journal research so you can understand the background, research stage and scope of each finding.

C2

Internal strategy information · 2026

Annual shareholders’ meeting presentation, ROC year 115 (2026), version 0625

Refer to the AI ​​tool introduction guidance on page 7, and the internal control, governance and capital market preparation directions on pages 10 and 30; internal financial and business conditions or unimplemented plans are not regarded as public results.

Governance and capital-market information is disclosed within the approved scope, with subsequent developments communicated through formal announcements.

C3

Cabinet Buying Center Announcement · 2017

Announcement of eGreen Biotek Corp. registration on the Go Incubation Board

Document number: Zhengaixinzi No. 10600256991; stock code 7525, company abbreviation eGreen Biotek. This announcement is for historical milestones and not for inferring real-time market status.

Original announcement of cabinet buying center
C4

Public media reports · 2025.05.15

Cooperation between eGreen and AMP Laboratory and planning of mushroom technology center

Source: Daqian Radio/Yahoo News. Used to confirm the then disclosed descriptions of raw material supply, OEM and North American market cooperation.

The description of the factory area and regulations in the article is the current plan and does not mean that this website has verified the completion of the facility, GMP certification or FDA approval.

Read the original report
C5

CEO education & career

Juiche Hsieh: biography and career information

Juiche Hsieh served as eGreen Biotek's CTO from 2009 to 2016 and has served as CEO since 2016. His education and international roles are documented in the eGreen Biotek Juiche Hsieh biography and professional profile.

LinkedIn profile
C6

Taipei Exchange official framework

GISA purpose and framework

Taipei Exchange describes GISA's business-advisory and equity-fundraising role and explicitly states that the platform does not provide trading. This source explains the distinction between GISA and other market boards.

About GISA

Government plans and industry-university information

We provide dates, research directions and references for past programs. Dates prioritize public government approvals, followed by earlier project records; differences between versions are noted for each project. Application documents containing personal contact or business information are summarized only as needed.

G1

Company plan information · 2022

Hsinchu City local SBIR initial review presentation, ROC year 111 (2022)

File: 111eGreen Biotek-Initial Review Report PPT220804_v2.pptx. Page 1 is the name, period and management organization of the project; Page 3 is the previous years’ plans; the rest of the research content is interpreted according to the initial plan.

G2

Company plan information · 2020

Application Brief for Instant Counseling for Small and Medium-sized Manufacturing Industries

File: 1091104 Small and medium-sized manufacturing industry instant tutoring application brief R2.pptx. Page 6 lists the 103–108 government plans and food industry-university cooperation, and subsequent pages describe instant powder development and expected benefits. The application and calendar do not replace the approval letter or case closing information.

G3

Application and review information · 2023

Technical-assistance documents on bioprocessed cereal-flour materials, ROC year 112 (2023)

In 2023, we applied for technical assistance for bioprocessed cereal-flour materials under the then Industrial Development Bureau of the Ministry of Economic Affairs, with the Food Industry Research and Development Institute as the technical-assistance body. References include application version 1120322-final and the review presentation dated March 31, 2023. Quantified improvements are application targets, not measured outcomes.

G4

Government’s public subsidy records

Approval record of Sanghuang machining process optimization plan

Our Sanghuang process-optimization project was approved on November 6 of ROC year 103, as recorded in the Industrial Development Bureau's public quarterly subsidy report. We use this approval date, which differs from the year shown in the 2026 retrospective version.

The Ministry of Economic Affairs discloses subsidy records
G5

Government’s public subsidy records · 2016

Approval record of LED cultivation fruiting body mass production plan

Our LED-cultivated fruiting-body scale-up project was approved on July 4 of ROC year 105, as recorded on page 2 of the Industrial Development Bureau's third-quarter report for that year. Subsidy approval, technical outcomes and project completion are verified separately.

The Ministry of Economic Affairs discloses subsidy records
G6

R&D experiment records · 2021

Just-in-time tutoring program pilot briefing

File: real-time tutoring plan.pptx. Save records of cell tests, immune-related indicators and component analysis in 2021; they are only used to confirm existing test data and will not be regarded as human efficacy or government case closure results.

Original drawings and authorization of literature experiments

The research page contains six sets of figures (eight original figure files) of R2, R10, and R13, obtained through the Europe PMC open access API, and presented under the CC BY 4.0 license indicated in each paper. The complete original image is retained and only scaled by the web page; the author, image number, source and authorization are listed below the image. The Chinese introduction is compiled by this website and does not constitute an endorsement of eGreen by the original author or the journal.

Go to the original image of the experiment · Download chart source and authorization record · CC BY 4.0 License Terms